volume 8, issue 4, P404-409 2010
DOI: 10.1590/s1679-45082010ao1789
View full text
|
|
Share

Abstract: Our data show that long-term oral administration of BAY 41-2272 counteracts the bladder dysfunction seen in NO-deficient rats, indicating that restoration of the NO-cGMP pathway by this compound may be of beneficial value to treat bladder symptoms.

Search citation statements

Order By: Relevance

Paper Sections

0
0
0
0
0

Citation Types

1
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals